Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akitada Ichinose

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Seminars in Thrombosis and Hemostasis|August 2, 2011
Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisitedAkitada Ichinose
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 14, 2015
[Diagnosis and treatment of acquired factor XIII/13 deficiencies: for all doctors treating the MHLW's designated intractable diseases]Akitada Ichinose
Blood Reviews|August 21, 2016
Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patientsAkitada Ichinose,
Seminars in Thrombosis and Hemostasis|September 13, 2014
Inhibitors of Factor XIII/13 in older patientsAkitada Ichinose,
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 9, 2019
[Immune-mediated acquired coagulation factor deficiencies: state-of-the-art in diagnosis and management]Akitada Ichinose
International Journal of Hematology|April 6, 2012
Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection controlAkitada Ichinose
Brain and Nerve = Shinkei Kenkyu No Shinpo|December 17, 2008
[Hyperlipoprotein (a)-emia determined by genetic polymorphisms in apolipoprotein (a) gene]Akitada Ichinose
Seminars in Thrombosis and Hemostasis|June 12, 2025
Immune-Related and Non-Immune-Related Acquired Factor XIII deficiencyAkitada Ichinose
Seminars in Thrombosis and Hemostasis|April 8, 2025
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese PracticeAkitada Ichinose
International Journal of Hematology|December 30, 2011
Reduced difference of α₂-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to anti-factor XIII antibodiesAkitada Ichinose, Masayoshi Souri
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Seminars in Thrombosis and Hemostasis|August 2, 2011
Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisitedAkitada Ichinose
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 14, 2015
[Diagnosis and treatment of acquired factor XIII/13 deficiencies: for all doctors treating the MHLW's designated intractable diseases]Akitada Ichinose
Blood Reviews|August 21, 2016
Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: A summary of 93 patientsAkitada Ichinose,
Seminars in Thrombosis and Hemostasis|September 13, 2014
Inhibitors of Factor XIII/13 in older patientsAkitada Ichinose,
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 9, 2019
[Immune-mediated acquired coagulation factor deficiencies: state-of-the-art in diagnosis and management]Akitada Ichinose
International Journal of Hematology|April 6, 2012
Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection controlAkitada Ichinose
Brain and Nerve = Shinkei Kenkyu No Shinpo|December 17, 2008
[Hyperlipoprotein (a)-emia determined by genetic polymorphisms in apolipoprotein (a) gene]Akitada Ichinose
Seminars in Thrombosis and Hemostasis|June 12, 2025
Immune-Related and Non-Immune-Related Acquired Factor XIII deficiencyAkitada Ichinose
Seminars in Thrombosis and Hemostasis|April 8, 2025
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese PracticeAkitada Ichinose
International Journal of Hematology|December 30, 2011
Reduced difference of α₂-plasmin inhibitor levels between plasma and serum in patients with severe factor XIII deficiency, including autoimmune hemorrhaphilia due to anti-factor XIII antibodiesAkitada Ichinose, Masayoshi Souri
Pageof 9